Insider · CIK 0001830371

Bodenrader Mark

Reports to the SEC for 1 company · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001830371

Forms 4 and 5

Insider transactions

18 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-08-01	Cerevel Therapeutics Holdings, Inc.D Disposition to Issuer	See Remarks	DDisposition to Issuer	−17.7K sh	—	—	0
2024-08-01	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−278K sh	—	—	0
2024-08-01	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsD Disposition to Issuer	See Remarks	DDisposition to Issuer	−24.9K sh	—	—	0
2024-01-19	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsA Award	See Remarks	AAward	+24.9K sh	—	—	24,852
2023-12-20	Cerevel Therapeutics Holdings, Inc.S Sale	See Remarks	SSale	−7,889 sh	$41.42	−$327K	17,724
2023-12-19	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+14.2K sh	—	—	20,528
2023-12-19	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+5,085 sh	—	—	25,613
2023-12-19	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−14.2K sh	—	—	0
2023-12-19	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−5,085 sh	—	—	0
2023-06-02	Cerevel Therapeutics Holdings, Inc.S Sale	See Remarks	SSale	−1,895 sh	$32.95	−$62.4K	5,522
2023-06-01	Cerevel Therapeutics Holdings, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+4,733 sh	—	—	7,417
2023-06-01	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−4,733 sh	—	—	14,199
2023-02-06	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award	See Remarks	AAward	+20K sh	—	—	20,012
2023-02-06	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsA Award	See Remarks	AAward	+5,085 sh	—	—	5,085
2022-06-01	Cerevel Therapeutics Holdings, Inc.Restricted Stock UnitsA Award	See Remarks	AAward	+18.9K sh	—	—	18,932
2022-02-09	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award	See Remarks	AAward	+24.8K sh	—	—	24,800
2021-02-03	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award	See Remarks	AAward	+90K sh	—	—	90,000
2020-10-28	Cerevel Therapeutics Holdings, Inc.Stock Option (Right to Buy)A Award	See Remarks	AAward	+65.4K sh	—	—	65,445

Recent filings

Accepted (ET)
Aug 54
Bodenrader Mark0000950170-24-090801
SEC(opens sec.gov)
Jan 234
Bodenrader Mark0000950170-24-006678
SEC(opens sec.gov)
Dec 214
Bodenrader Mark0000950170-23-072381
SEC(opens sec.gov)
Jun 54
Bodenrader Mark0000950170-23-026500
SEC(opens sec.gov)
Feb 84
Bodenrader Mark0000899243-23-004358
SEC(opens sec.gov)
Jun 34
Bodenrader Mark0000899243-22-020994
SEC(opens sec.gov)
Feb 114
Bodenrader Mark0000899243-22-005942
SEC(opens sec.gov)
Feb 54
Bodenrader Mark0000899243-21-005096
SEC(opens sec.gov)
Oct 304
Bodenrader Mark0000899243-20-030026
SEC(opens sec.gov)

Companies

Cerevel Therapeutics Holdings, Inc.See Remarks

Address

C/O CEREVEL THERAPEUTICS HOLDINGS, INC. 131 DARTMOUTH STREET, SUITE 502

BOSTON, MA, 02116